How to make the most of your weight loss journey Ozempic, Wegovy, Mounjaro (oh my). While GLP-1 agonists like these were originally used to manage type 2 diabetes or reduce the risk of heart ...
Compounded GLP-1s for Weight Loss: What Are They and Are They Safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
Axios Visuals Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows. Why it matters: The restrictive ...
Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with greater weight loss than bariatric surgery alone, suggested an ...
Medicines affecting the GLP-1 receptor are in vogue for weight loss right now. Zealand Pharma has GLP-1 candidates, but also a compelling alternative approach. BioAge Labs' lead program could ...
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...
Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in ... [+] five large employers are covering such prescriptions, a new KFF analysis shows. In this ...
Sales of GLP-1 weight-loss medications like Wegovy and Zepbound (tirzepatide) have boomed among adults, and with 1 in every 5 U.S. children now obese, the drugs' uptake by adolescents is also surging.
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds. Prescriptions of this GLP-1 class ...
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.
GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 weight ...